Please use this identifier to cite or link to this item:
Title: Comparison between Obtained Mydriasis in Type 2 Diabetics and Non-Diabetic Patients
Authors: Coblentz, Jacqueline
Motta, Mario M. S.
Fernandes, Bruno F.
Burnier, Miguel N. [UNIFESP]
Vianna, Raul N. G.
Fed Univ State Rio de Janeiro UNIRIO
McGill Univ
Universidade Federal de São Paulo (UNIFESP)
Universidade Federal Fluminense (UFF)
Keywords: Adrenergic drugs
Diabetes mellitus
Fundus examination
Mydriatic drugs
Pupil diameter
Issue Date: 1-Jan-2009
Publisher: Taylor & Francis Inc
Citation: Current Eye Research. Philadelphia: Taylor & Francis Inc, v. 34, n. 11, p. 925-927, 2009.
Abstract: Background/Aims: To evaluate and compare obtained mydriasis with phenylephrine 10% associated with tropicamide 1% in type 2 diabetics and non-diabetic patients. Methods: A total of 50 patients ( 100 eyes) scheduled for fundoscopy were dilated with phenylephrine 10% and yropicamide 1% (group 0: n=20 type 2 diabetic patients, 40 eyes, and group 1: n=30 non-diabetic patients, 60 eyes). Only one drop per eye of each drug was administered. in both groups, pupil diameter was measured after 40 minutes of eye drops instillation.Results: Both groups were similar regarding age (p = 0.06, Mann-Whitney test). Mean pupil diameter in group 0 was 8.57 and 8.73 in group 1. There was no statistic difference between both groups (p = 0.44). Pupil diameter was greater than 7 mm in all patients (100%).Conclusion: When an appropriate drug combination is used, diabetic patients can achieve mydriasis as satisfactory as non-diabetic patients, allowing adequate fundus examination and/or retinopathy treatment.
ISSN: 0271-3683
Other Identifiers:
Appears in Collections:Em verificação - Geral

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.